Vision-related Quality of Life in Patients with Non-infectious Uveitis: A Cross-sectional Study

REFERENCES

• Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: A literature survey. Br J Ophthalmol. 1996;80:844–848. doi:10.1136/bjo.80.9.844.
   PubMed Web of Science ®Google Scholar
• Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. 1996;80(4):332–336.
   PubMed Web of Science ®Google Scholar
• Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: A literature survey. Br J Ophthalmol. 1996;80(9):844–848.
   PubMed Web of Science ®Google Scholar
• De Smet MD, Taylor SRJ, Bodaghi B, et al. Understanding uveitis: The impact of research on visual outcomes. Prog Retin Eye Res. 2011;30:452–470. doi:10.1016/j.preteyeres.2011.06.005.
   PubMed Web of Science ®Google Scholar
• Williams GJ, Brannan S, Forrester JV, et al. The prevalence of sight-threatening uveitis in Scotland. Br J Ophthalmol. 2007;91:33–36. doi:10.1136/bjo.2006.101386.
   PubMed Web of Science ®Google Scholar
• Wakefield D, Chang JH. Epidemiology of uveitis. Int Ophthalmol Clin. 2005;45:1–13. doi:10.1097/01.iio.0000155938.83083.94.
   PubMedGoogle Scholar
• Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern California: The Northern California Epidemiology of Uveitis Study. Ophthalmology. 2004;111:491–500. doi:10.1016/j.ophtha.2003.06.014.
   PubMed Web of Science ®Google Scholar
• Chang JH-M, Wakefield D. Uveitis: A global perspective. Ocul Immunol Inflamm. 2002;10:263–279. doi:10.1076/ocii.10.4.263.15592.
   PubMed Web of Science ®Google Scholar
• Rothova a, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. 1996;80:332–336. doi:10.1136/bjo.80.4.332.
   Web of Science ®Google Scholar
• De Smet MD, Taylor SRJ, Bodaghi B, et al. Understanding uveitis: The impact of research on visual outcomes. Prog Retin Eye Res. 2011;30:452–470. doi:10.1016/j.preteyeres.2011.06.005.
   PubMed Web of Science ®Google Scholar
• E. Kirbach, S., A. Hayes, O., A. Cifaldi M. The economic burden of uveitis. Arthritis Rheum. 2010;62(Suppl10):788. doi:10.1002/art.28556.
   Google Scholar
• Adán-Civera AM, Benítez-del-Castillo JM, Blanco-Alonso R, et al. Carga y costes directos de la uveítis no infecciosa en España. Reumatol Clín. 2015. doi:10.1016/j.reuma.2015.08.004.
   PubMedGoogle Scholar
• Durrani OM, Meads CA, Murray PI. Uveitis: A potentially blinding disease. Ophthalmologica. 2004;218:223–236. doi:10.1159/000078612.
   PubMed Web of Science ®Google Scholar
• Jalil A, Yin K, Coyle L, Harper R, Jones NP. Vision-related quality of life and employment status in patients with uveitis of working age: A prospective study. Ocul Immunol Inflamm. 2012;20:262–265. doi:10.3109/09273948.2012.684420.
   PubMed Web of Science ®Google Scholar
• Bradley E A, Bradley D, Bartley GB. Evaluating health-related quality of life in ophthalmic disease: Practical considerations. Arch Ophthalmol. 2006;124:121–122. doi:10.1001/archopht.124.1.121.
   PubMedGoogle Scholar
• Miserocchi E, Modorati G, Mosconi P, et al. Quality of life in patients with uveitis on chronic systemic immunosuppressive treatment. Ocul Immunol Inflamm. 2010;18:297–304. doi:10.3109/09273941003637510.
   PubMed Web of Science ®Google Scholar
• Murphy CC, Hughes EH, Frost NA, Dick AD. Quality of life and visual function in patients with intermediate uveitis. Br J Ophthalmol. 2005;89:1161–1165. doi:10.1136/bjo.2005.067421.
   PubMed Web of Science ®Google Scholar
• Schiffman RM, Jacobsen G, Whitcup SM. Visual functioning and general health status in patients with uveitis. Arch Ophthalmol. 2001;119:841–849. doi:10.1097/00132578-200204000-00015.
   PubMed Web of Science ®Google Scholar
• Gui W, Dombrow M, Marcus I, et al. Quality of life in patients with noninfectious uveitis treated with or without systemic anti-inflammatory therapy. Ocul Immunol Inflamm. 2015;23:135–143. doi:10.3109/09273948.2013.874445.
   PubMed Web of Science ®Google Scholar
• Gardiner AM, Armstrong RA, Dunne MCM, Murray PI. Correlation between visual function and visual ability in patients with uveitis. Br J Ophthalmol. 2002;86:993–996.
   PubMed Web of Science ®Google Scholar
• Murphy CC, Greiner K, Plskova J, et al. Validity of using vision-related quality of life as a treatment end point in intermediate and posterior uveitis. Br J Ophthalmol. 2007;91:154–156. doi:10.1136/bjo.2006.105528.
   PubMed Web of Science ®Google Scholar
• Bañares A, Jover JA, Fernández-Gutiérrez B, et al. Patterns of uveitis as a guide in making rheumatologic and immunologic diagnoses. Arthritis Rheum. 1997;40(2):358–370.
   PubMed Web of Science ®Google Scholar
• Abásolo L, Prieto-García Á, Díaz-Valle D, et al. Influence of baseline demographic and clinical characteristics in the visual outcome of intermediate uveitis: a survival analysis. Br J Ophthalmol. 2016. doi:10.1136/bjophthalmol-2015-307774.
   PubMed Web of Science ®Google Scholar
• Abásolo L, Rosales Z, Díaz-Valle D, et al. Immunosuppressive drug discontinuation in noninfectious uveitis from real-life clinical practice: a survival analysis. Am J Ophthalmol. 2016;169:1–8. doi:10.1016/j.ajo.2016.06.007.
   PubMed Web of Science ®Google Scholar
• World Medical Association. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA. 2013;310:2191–2194. doi:10.1001/jama.2013.281053.
   PubMed Web of Science ®Google Scholar
• Jabs DA. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. vol. 140;2005:509–516. doi:10.1016/j.ajo.2005.03.057.
   PubMed Web of Science ®Google Scholar
• Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119:1050–1058. doi:10.1097/00132578-200201000-00028.
   PubMed Web of Science ®Google Scholar
• Naik RK, Rentz AM, Foster CS, et al. Normative comparison of patient-reported outcomes in patients with noninfectious uveitis. JAMA Ophthalmol. 2013;131:219–225. doi:10.1001/2013.jamaophthalmol.102.
   PubMed Web of Science ®Google Scholar
• Broman AT, Munoz B, West SK, et al. Psychometric properties of the 25-item NEI-VFQ in a hispanic population: Proyecto VER. Investig Ophthalmol Vis Sci. 2001;42:606–613.
   PubMed Web of Science ®Google Scholar
• Globe DR, Varma R, Azen SP, et al. Psychometric performance of the NEI VFQ-25 in visually normal latinos: The Los Angeles Latino Eye Study. Investig Ophthalmol Vis Sci. 2003;44:1470–1478. doi:10.1167/iovs.02-0292.
   PubMed Web of Science ®Google Scholar
• Mangione CM. NEI VFQ-25 Scoring Algorithm. National Eye Institute. https://www.nei.nih.gov/sites/default/files/nei-pdfs/manual_cm2000.pdf. Published 2000.
   Google Scholar
• Mangione CM, Lee PP, Pitts J, et al. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol. 1998;116:1496–1504. doi:10-1001/pubs.Ophthalmol.-ISSN-0003-9950-116-11-eeb8310.
   Google Scholar
• Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol. 1989;129:125–137. doi:10.1093/oxfordjournals.aje.a115409.
   PubMed Web of Science ®Google Scholar
• Tan P, Koh YT, Wong PY, Teoh SC. Evaluation of the impact of uveitis on visual-related quality of life. Ocul Immunol Inflamm. 2012;20:453–459. doi:10.3109/09273948.2012.723781.
   PubMed Web of Science ®Google Scholar
• Hui MM, Wakefield D, Patel I, et al. Visual functioning and health-related quality-of-life are compromised in patients with uveitis. Ocul Immunol Inflamm. 2016:1–6. doi:10.3109/09273948.2016.1139734.
   PubMed Web of Science ®Google Scholar
• Naik RK, Gries KS, Rentz AM, et al. Psychometric evaluation of the National Eye Institute Visual Function Questionnaire and Visual Function Questionnaire Utility Index in patients with non-infectious intermediate and posterior uveitis. Qual Life Res. 2013;22:2801–2808. doi:10.1007/s11136-013-0412-y.
   PubMed Web of Science ®Google Scholar
• Frick KD, Drye LT, Kempen JH, et al. Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial. Invest Ophthalmol Vis Sci. 2012;53:1169–1176. doi:10.1167/iovs.11-8259.
   PubMed Web of Science ®Google Scholar
• Kuiper JJW, Missotten T, Baarsma SG, Rothova A. Vision-related quality of life in patients with birdshot chorioretinopathy. Acta Ophthalmol. 2013;91. doi:10.1111/aos.12054.
   PubMed Web of Science ®Google Scholar
• Lin P, Loh AR, Margolis TP, Acharya NR. Cigarette smoking as a risk factor for uveitis. Ophthalmology. 2010;117:585–590. doi:10.1016/j.ophtha.2009.08.011.
   PubMed Web of Science ®Google Scholar
• Borkar DS, Tham VM, Shen E, et al. Association between statin use and uveitis: results from the pacific ocular inflammation study. Am J Ophthalmol. 2015;159:707–713.e2. doi:10.1016/j.ajo.2015.01.009.
   PubMed Web of Science ®Google Scholar
• Roesel M, Ruttig A, Schumacher C, et al. Smoking complicates the course of non-infectious uveitis. Graefe’s Arch Clin Exp Ophthalmol = Albr von Graefes Arch für Klin und Exp Ophthalmol. 2011;249:903–907. doi:10.1007/s00417-010-1597-1.
   PubMed Web of Science ®Google Scholar
• Galor A, Feuer W, Kempen JH, et al. Adverse effects of smoking on patients with ocular inflammation. Br J Ophthalmol. 2010;94:848–853. doi:10.1136/bjo.2009.174466.
   PubMed Web of Science ®Google Scholar
• Thorne JE, Daniel E, Jabs DA, et al. Smoking as a risk factor for cystoid macular edema complicating intermediate uveitis. Am J Ophthalmol. 2008;145:841–846. doi:10.1016/j.ajo.2007.12.032.
   PubMed Web of Science ®Google Scholar
• Jaffe GJ, Dick AD, Brézin AP, et al. Adalimumab in patients with active noninfectious uveitis. N Engl J Med. 2016;375:932–943. doi:10.1056/NEJMoa1509852.
   PubMed Web of Science ®Google Scholar
• Sheppard J, Joshi AD, Mittal M, et al. Effect of adalimumab on visual functioning (VFQ-25) in visual-1 trial patients with non-anterior non-infectious uveitis [abstract]. Arthritis Rheumatol. 2015;67(suppl 10).
   Google Scholar
• McKee M, Britton A, Black N, et al. Methods in health services research. Interpreting the evidence: Choosing between randomised and non-randomised studies. BMJ. 1999;319(7205):312–315.
   PubMed Web of Science ®Google Scholar